Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001555667-15-000001
Filing Date
2015-01-14
Accepted
2015-01-14 19:41:37
Documents
1
Period of Report
2015-01-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3756
  Complete submission text file 0001555667-15-000001.txt   5096
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
ARBIGE MICHAEL V (Reporting) CIK: 0001225608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35189 | Film No.: 15528180

Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Issuer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals